Northwire Canada EditionFriday, July 10, 2026
Northwire
TLO 5.37 +5.7% BNKR 4.88 +1.7% GG 2.25 +3.2% MJS 0.100 +5.3% PAAS 62.54 +3.6% PE 0.230 +0.0% SGML 17.19 +4.8% LAR 10.34 −1.1% NED 0.025 +0.0% GEN 0.080 +0.0% TVI 0.060 +0.0% SKYG 0.025 −37.5% WRLG 0.660 +6.5% FFU 0.120 −7.7% LOD 0.310 +3.3% CBI 0.110 +0.0% TLO 5.37 +5.7% BNKR 4.88 +1.7% GG 2.25 +3.2% MJS 0.100 +5.3% PAAS 62.54 +3.6% PE 0.230 +0.0% SGML 17.19 +4.8% LAR 10.34 −1.1% NED 0.025 +0.0% GEN 0.080 +0.0% TVI 0.060 +0.0% SKYG 0.025 −37.5% WRLG 0.660 +6.5% FFU 0.120 −7.7% LOD 0.310 +3.3% CBI 0.110 +0.0%
Financings Routine −

Arianne extends credit facilities with Mercury

DAN · Price

Executive Summary

  • Arianne Phosphate Inc. closed an amended and restated senior secured credit agreement with Mercury Financing Corp., extending three existing facilities to a total of $24.48 M maturing on 30 Sept 2027.
  • The transaction involved the issuance of 7,539,515 common shares (partial cash consideration) and a further 10 M common shares subject to voluntary hold periods, plus 25 M non‑transferable warrants at $0.28 per share.
  • Mercury gains board representation rights, a production fee of $0.25 per tonne of phosphate concentrate for the life of the project (repurchasable for $2.25 M), and potential ownership up to ~16.6 % on a partially diluted basis if all warrants are exercised.

Key Details

  • Credit Facilities: Aggregate principal amount $24,477,128; interest rate 8 % per annum, capitalized to maturity.
  • Share Issuance – Accrued Interest Payment:
  • 7,539,515 common shares issued to cover accrued interest up to 31 Mar 2026.
  • 7,118,742 shares sold at $0.26 each (interest from 1 Apr 2025‑11 Mar 2026).
  • 420,773 shares sold at $0.255 each (interest from 12 Mar 2026‑closing).
  • Equity Issuance – Additional Shares:
  • 10 M common shares issued to Mercury.
  • Voluntary hold periods: 5 M shares – 6 months; 5 M shares – 9 months from closing.
  • Hold periods may be shortened by a subsequent equity financing or terminated upon a merger/acquisition.
  • Warrants:
  • 25 M non‑transferable common share purchase warrants, exercisable at $0.28 per share until 30 Sept 2027.
  • Exercise limited to keep Mercury’s ownership ≤19.9 % on a partially diluted basis, unless a business combination occurs.
  • Board Rights: Mercury may designate a nominee to the Arianne board and that nominee will sit on the Human Resources & Corporate Governance Committee for as long as the loan remains outstanding.
  • Production Fee: Additional fee of $0.25 per metric tonne of phosphate concentrate sales for the project life, payable to Mercury; can be repurchased by Arianne for a lump‑sum $2.25 M at any time. Same fee applies if full repayment is not made by 31 Mar 2027.
  • Regulatory Hold: Interest‑payment shares, the 2026 equity issuance and warrants are subject to a regulatory hold expiring 1 Aug 2026; transaction pending final TSX‑V approval.
  • Post‑Closing Ownership (early warning):
  • Mercury beneficially owns 17,539,515 common shares (~7.6 % non‑diluted).
  • Plus 25 M warrants; if exercised, total potential ownership rises to 42,539,515 shares, ~16.6 % partially diluted.
  • Future Flexibility: Mercury may acquire additional securities in the open market at any time and may dispose of holdings as it sees fit.

Notable Quotes

(No direct CEO/President quotes were included in the release.)

Read the original news release →

More from Arianne Phosphate Inc.